These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 7895178

  • 1. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H, Ljunggren O, Larsson K, Lindh E, Ljunghall S.
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [Abstract] [Full Text] [Related]

  • 2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 3. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
    Legovini P, De Menis E, Da Rin G, Roiter I, Breda F, Artuso V, Di Virgilio R, Conte N.
    Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
    [Abstract] [Full Text] [Related]

  • 4. Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery.
    Minisola S, Romagnoli E, Scarnecchia L, Rosso R, Pacitti MT, Scarda A, Mazzuoli G.
    Eur J Endocrinol; 1994 Jun; 130(6):587-91. PubMed ID: 8205259
    [Abstract] [Full Text] [Related]

  • 5. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Jun; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Costantini S, Chicca S, De Meo S, Perruzza I, Sardella D, Taggi F.
    Nephrol Dial Transplant; 1995 Jun; 10(1):52-8. PubMed ID: 7724029
    [Abstract] [Full Text] [Related]

  • 7. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
    Zerwekh JE, Padalino P, Pak CY.
    Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
    [Abstract] [Full Text] [Related]

  • 8. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N, Parés A, Alvarez L, Martínez de Osaba MJ, Monegal A, Peris P, Ballesta AM, Rodés J.
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [Abstract] [Full Text] [Related]

  • 9. [Markers of bone formation and resorption in primary and secondary hyperparathyroidism].
    Kosowicz J, Baszko-Błaszyk D, Horst-Sikorska W, Ruszkowska J.
    Pol Arch Med Wewn; 1998 Apr; 99(4):287-97. PubMed ID: 9760816
    [Abstract] [Full Text] [Related]

  • 10. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
    Gram J, Junker P, Nielsen HK, Bollerslev J.
    Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
    [Abstract] [Full Text] [Related]

  • 11. Serum concentrations of carboxyterminal cross-linked telopeptide of type I collagen (ICTP), serum tartrate resistant acid phosphatase, and serum levels of intact parathyroid hormone in parathyroid hyperfunction.
    De la Piedra C, Díaz Martín MA, Díaz Diego EM, López Gavilanes E, González Parra E, Caramelo C, Rapado A.
    Scand J Clin Lab Invest; 1994 Feb; 54(1):11-5. PubMed ID: 8171266
    [Abstract] [Full Text] [Related]

  • 12. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A, Torta M, Piovesan A, Raucci CA, Orlandi F, Panero A, Dogliotti L, Angeli A.
    Anticancer Res; 1995 Feb; 15(6B):2871-5. PubMed ID: 8669881
    [Abstract] [Full Text] [Related]

  • 13. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N, Bentzen SM, Nielsen JL, Heickendorff L.
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [Abstract] [Full Text] [Related]

  • 14. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
    Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A.
    J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
    [Abstract] [Full Text] [Related]

  • 15. Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
    Gram J, Junker P, Nielsen HK, Bollerslev J.
    Bone; 1996 Jun; 18(6):539-44. PubMed ID: 8805994
    [Abstract] [Full Text] [Related]

  • 16. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients.
    Sorva A, Välimäki M, Risteli J, Risteli L, Elfving S, Takkunen H, Tilvis R.
    Eur J Clin Invest; 1994 Dec; 24(12):806-12. PubMed ID: 7705374
    [Abstract] [Full Text] [Related]

  • 17. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D, Zwolińska D, Bednorz R, Owczarek H, Szymańska A, Nahaczewska W.
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K, Shiraishi K, Sakamoto A, Jojima H, Masuchi K, Okubo Y, Tanaka M, Fuzimatsu Y, Fukahori S, Osabe S, Imamura Y, Honda J, Oizumi K.
    Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
    [Abstract] [Full Text] [Related]

  • 19. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K.
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [Abstract] [Full Text] [Related]

  • 20. Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism.
    Kristoffersson A, Hultdin J, Holmlund I, Thorsen K, Lorentzon R.
    Int J Sports Med; 1995 Apr; 16(3):145-9. PubMed ID: 7649703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.